beta-lactam antibiotics offer neuroprotection increasing glutamate transporter expression
glutamate principal excitatory neurotransmitter nervous system inactivation synaptic glutamate handled glutamate transporter glt1 also known eaat2 refs physiologically dominant astroglial protein spite critical importance normal abnormal synaptic activity practical pharmaceutical can positively modulate protein animal studies show protein important normal excitatory synaptic transmission dysfunction implicated acute chronic neurological disorders including amyotrophic lateral sclerosis als stroke brain tumours epilepsy using blinded screen fda-approved drugs nutritionals discovered many beta-lactam antibiotics potent stimulators glt1 expression furthermore action appears mediated increased transcription glt1 gene beta-lactams various semi-synthetic derivatives potent antibiotics act inhibit bacterial synthetic pathways delivered animals beta-lactam ceftriaxone increased brain expression glt1 biochemical functional activity glutamate transporters important preventing glutamate neurotoxicity ceftriaxone neuroprotective vitro used models ischaemic injury motor neuron degeneration based part glutamate toxicity used animal model fatal disease als drug delayed loss neurons muscle strength increased mouse survival thus studies provide class potential neurotherapeutics act modulate expression glutamate neurotransmitter transporters via gene activation
